Bionic Sight

Bionic Sight Overview

Founded 2012
Status Private
Latest Deal Type Early Stage VC
Investors 1

Bionic Sight General Information


Developer of a medical device designed to develop and commercialize the prosthetic treatments for blindness due to retinal degenerative disease. The company's device uses retinal code that can convert visual images into similar patterns of an action potential that the retina normally produces and can do so across a broad range of stimuli including faces, landscapes, and movement, essentially replicating patterns in a code the brain is expecting and can recognize, enabling users to bring prosthetic capabilities up to the level of near-normal image representation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 430 East 63rd Street
  • Apartment 2-G
  • New York, NY 10065
  • United States
+1 (646) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bionic Sight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2014 Completed Generating Revenue

Bionic Sight Executive Team (2)

Name Title Board Seat Contact Info
Sheila Nirenberg Ph.D Co-Founder & Principal
William Hauswirth Ph.D Co-Founder

Bionic Sight Investors (1)

To view Bionic Sight‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Partnership for New York City Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial